Outset Medical Announces One-for-Fifteen Reverse Stock Split

Core Viewpoint - Outset Medical, Inc. has announced a one-for-fifteen reverse stock split, effective March 20, 2025, to reduce the number of outstanding shares and potentially enhance the stock's marketability [1][2]. Group 1: Reverse Stock Split Details - The reverse stock split was approved by stockholders on March 5, 2025, and will convert every 15 pre-split shares into one new share, reducing the total from approximately 265 million to about 17 million shares [2]. - The reverse stock split will not change stockholders' percentage ownership interests, except for fractional shares, which will be compensated with cash payments [3]. - The number of shares available under the Company's equity incentive plans and the exercise prices of outstanding options will be proportionately adjusted [4]. Group 2: Administrative Aspects - Equiniti Trust Company, LLC will act as the transfer agent for the reverse stock split, managing the issuance of post-split shares in a paperless format without requiring action from stockholders [5]. - Registered stockholders will automatically receive post-split shares, while those holding shares in "street name" will have their positions adjusted accordingly [5]. Group 3: Company Overview - Outset Medical is focused on pioneering technology to reduce the cost and complexity of dialysis, with its Tablo® Hemodialysis System representing a significant advancement in the field [7]. - The Tablo system allows for flexible dialysis delivery, integrating water purification and on-demand dialysate production, and is designed to enhance patient care and operational efficiency [7].